Toxicidade de fármacos nitrofurânicos

Detalhes bibliográficos
Autor(a) principal: Bosquesi, P. L. [UNESP]
Data de Publicação: 2008
Outros Autores: Almeida, Adelia Emilia de [UNESP], Blau, L. [UNESP], Menegon, R. F. [UNESP], Santos, Jean Leandro dos [UNESP], Chin, Chung Man [UNESP]
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://serv-bib.fcfar.unesp.br/seer/index.php/Cien_Farm/article/view/588
http://hdl.handle.net/11449/70774
Resumo: During the structural designing of new drugs, it is possible predict the influence of specific chemical groups on pharmacological activity. Among these, the nitro group has potential antiparasitic activity, being present in many antimicrobial drugs, such as metronidazole, nitrofurazone, furazolidone, oxamniquine and chloramphenicol. Also, the introduction of the nitro group into a molecule can modify the physicochemical and electronic properties of the substance. Besides antimicrobial drugs, this group is also found in other drug classes, such as antiulcer, anti-inflamatory and anxiolytic. However, the use of the nitro group in drug design has encountered restrictions, due to the associated toxicity. This article is a review of the toxicity of nitrofuran compounds, as well the possible mechanisms involved and the strategy of latentiation by molecular modification to decrease their toxicity.
id UNSP_b19510502401e6a759d41f04f0522b59
oai_identifier_str oai:repositorio.unesp.br:11449/70774
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Toxicidade de fármacos nitrofurânicosToxicity of nitrofuran drugsMechanismNitrofuranProdrugToxicitybenznidazolechloramphenicolclonazepamfurazolidonemetronidazolenifurtimoxnifurtoinolnimesulidenitrofuralnitrofuran derivativenitrofurantoinoxamniquineprimaquineranitidinesecnidazoletinidazoleantibacterial activitybacterial infectioncell proliferationchemical compositionchemical modificationchromosome breakageDNA damagedrug carcinogenicitydrug designdrug effectdrug structuregenotoxicityhumanLD 50leishmaniasismicronucleusmolecular mechanicsmutagenicitynonhumanquantitative structure activity relationreviewSalmonella typhimuriumtrypanosomiasisDuring the structural designing of new drugs, it is possible predict the influence of specific chemical groups on pharmacological activity. Among these, the nitro group has potential antiparasitic activity, being present in many antimicrobial drugs, such as metronidazole, nitrofurazone, furazolidone, oxamniquine and chloramphenicol. Also, the introduction of the nitro group into a molecule can modify the physicochemical and electronic properties of the substance. Besides antimicrobial drugs, this group is also found in other drug classes, such as antiulcer, anti-inflamatory and anxiolytic. However, the use of the nitro group in drug design has encountered restrictions, due to the associated toxicity. This article is a review of the toxicity of nitrofuran compounds, as well the possible mechanisms involved and the strategy of latentiation by molecular modification to decrease their toxicity.Durante o planejamento estrutural de novos fármacos, é possível prever a infl uência de grupamentos específi cos na atividade farmacológica. Entre estes, encontrase o grupo nitro, que possui potencial atividade antimicrobiana, estando presente em diversos fármacos como o metronidazol, nitrofural, furazolidona, oxamniquina, cloranfenicol, entre outros. Também, a introdução do grupo nitro na molécula pode alterar as propriedades físico-químicas e eletrônicas da substância, estando presente em fármacos de outras classes terapêuticas como anti-úlcera, ansiolítico, antiinfl amatório. Entretanto, restrições têm sido apontadas para o planejamento de novos fármacos contendo este grupo, devido à toxicidade relacionada. Este estudo trata-se da revisão sobre a toxicidade de compostos nitrofurânicos, bem como os possíveis mecanismos e a utilização do método de latenciação na diminuição desta toxicidade.Departamento de Fármacos e Medicamentos Faculdade de Ciências Farmacêuticas Universidade Estadual Paulista, UNESP, Rodovia Araraquara - Jaú, km 01, CEP 14801 -902-Araraquara - SPDepartamento de Fármacos e Medicamentos Faculdade de Ciências Farmacêuticas Universidade Estadual Paulista, UNESP, Rodovia Araraquara - Jaú, km 01, CEP 14801 -902-Araraquara - SPUniversidade Estadual Paulista (Unesp)Bosquesi, P. L. [UNESP]Almeida, Adelia Emilia de [UNESP]Blau, L. [UNESP]Menegon, R. F. [UNESP]Santos, Jean Leandro dos [UNESP]Chin, Chung Man [UNESP]2014-05-27T11:23:46Z2014-05-27T11:23:46Z2008-12-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article231-238application/pdfhttp://serv-bib.fcfar.unesp.br/seer/index.php/Cien_Farm/article/view/588Revista de Ciencias Farmaceuticas Basica e Aplicada, v. 29, n. 3, p. 231-238, 2008.1808-4532http://hdl.handle.net/11449/707742-s2.0-703491517512-s2.0-70349151751.pdf97343336079754130000-0003-4141-0455Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPporRevista de Ciências Farmacêuticas Básica e Aplicada0,131info:eu-repo/semantics/openAccess2023-10-19T06:07:46Zoai:repositorio.unesp.br:11449/70774Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462023-10-19T06:07:46Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Toxicidade de fármacos nitrofurânicos
Toxicity of nitrofuran drugs
title Toxicidade de fármacos nitrofurânicos
spellingShingle Toxicidade de fármacos nitrofurânicos
Bosquesi, P. L. [UNESP]
Mechanism
Nitrofuran
Prodrug
Toxicity
benznidazole
chloramphenicol
clonazepam
furazolidone
metronidazole
nifurtimox
nifurtoinol
nimesulide
nitrofural
nitrofuran derivative
nitrofurantoin
oxamniquine
primaquine
ranitidine
secnidazole
tinidazole
antibacterial activity
bacterial infection
cell proliferation
chemical composition
chemical modification
chromosome breakage
DNA damage
drug carcinogenicity
drug design
drug effect
drug structure
genotoxicity
human
LD 50
leishmaniasis
micronucleus
molecular mechanics
mutagenicity
nonhuman
quantitative structure activity relation
review
Salmonella typhimurium
trypanosomiasis
title_short Toxicidade de fármacos nitrofurânicos
title_full Toxicidade de fármacos nitrofurânicos
title_fullStr Toxicidade de fármacos nitrofurânicos
title_full_unstemmed Toxicidade de fármacos nitrofurânicos
title_sort Toxicidade de fármacos nitrofurânicos
author Bosquesi, P. L. [UNESP]
author_facet Bosquesi, P. L. [UNESP]
Almeida, Adelia Emilia de [UNESP]
Blau, L. [UNESP]
Menegon, R. F. [UNESP]
Santos, Jean Leandro dos [UNESP]
Chin, Chung Man [UNESP]
author_role author
author2 Almeida, Adelia Emilia de [UNESP]
Blau, L. [UNESP]
Menegon, R. F. [UNESP]
Santos, Jean Leandro dos [UNESP]
Chin, Chung Man [UNESP]
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Bosquesi, P. L. [UNESP]
Almeida, Adelia Emilia de [UNESP]
Blau, L. [UNESP]
Menegon, R. F. [UNESP]
Santos, Jean Leandro dos [UNESP]
Chin, Chung Man [UNESP]
dc.subject.por.fl_str_mv Mechanism
Nitrofuran
Prodrug
Toxicity
benznidazole
chloramphenicol
clonazepam
furazolidone
metronidazole
nifurtimox
nifurtoinol
nimesulide
nitrofural
nitrofuran derivative
nitrofurantoin
oxamniquine
primaquine
ranitidine
secnidazole
tinidazole
antibacterial activity
bacterial infection
cell proliferation
chemical composition
chemical modification
chromosome breakage
DNA damage
drug carcinogenicity
drug design
drug effect
drug structure
genotoxicity
human
LD 50
leishmaniasis
micronucleus
molecular mechanics
mutagenicity
nonhuman
quantitative structure activity relation
review
Salmonella typhimurium
trypanosomiasis
topic Mechanism
Nitrofuran
Prodrug
Toxicity
benznidazole
chloramphenicol
clonazepam
furazolidone
metronidazole
nifurtimox
nifurtoinol
nimesulide
nitrofural
nitrofuran derivative
nitrofurantoin
oxamniquine
primaquine
ranitidine
secnidazole
tinidazole
antibacterial activity
bacterial infection
cell proliferation
chemical composition
chemical modification
chromosome breakage
DNA damage
drug carcinogenicity
drug design
drug effect
drug structure
genotoxicity
human
LD 50
leishmaniasis
micronucleus
molecular mechanics
mutagenicity
nonhuman
quantitative structure activity relation
review
Salmonella typhimurium
trypanosomiasis
description During the structural designing of new drugs, it is possible predict the influence of specific chemical groups on pharmacological activity. Among these, the nitro group has potential antiparasitic activity, being present in many antimicrobial drugs, such as metronidazole, nitrofurazone, furazolidone, oxamniquine and chloramphenicol. Also, the introduction of the nitro group into a molecule can modify the physicochemical and electronic properties of the substance. Besides antimicrobial drugs, this group is also found in other drug classes, such as antiulcer, anti-inflamatory and anxiolytic. However, the use of the nitro group in drug design has encountered restrictions, due to the associated toxicity. This article is a review of the toxicity of nitrofuran compounds, as well the possible mechanisms involved and the strategy of latentiation by molecular modification to decrease their toxicity.
publishDate 2008
dc.date.none.fl_str_mv 2008-12-01
2014-05-27T11:23:46Z
2014-05-27T11:23:46Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://serv-bib.fcfar.unesp.br/seer/index.php/Cien_Farm/article/view/588
Revista de Ciencias Farmaceuticas Basica e Aplicada, v. 29, n. 3, p. 231-238, 2008.
1808-4532
http://hdl.handle.net/11449/70774
2-s2.0-70349151751
2-s2.0-70349151751.pdf
9734333607975413
0000-0003-4141-0455
url http://serv-bib.fcfar.unesp.br/seer/index.php/Cien_Farm/article/view/588
http://hdl.handle.net/11449/70774
identifier_str_mv Revista de Ciencias Farmaceuticas Basica e Aplicada, v. 29, n. 3, p. 231-238, 2008.
1808-4532
2-s2.0-70349151751
2-s2.0-70349151751.pdf
9734333607975413
0000-0003-4141-0455
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv Revista de Ciências Farmacêuticas Básica e Aplicada
0,131
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 231-238
application/pdf
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1797789444413063168